for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shandong Lukang Pharmaceutical Co., Ltd

600789.SS

Latest Trade

7.56CNY

Change

-0.10(-1.31%)

Volume

21,304,892

Today's Range

7.44

 - 

7.69

52 Week Range

7.10

 - 

11.15

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7.66
Open
7.56
Volume
21,304,892
3M AVG Volume
224.53
Today's High
7.69
Today's Low
7.44
52 Week High
11.15
52 Week Low
7.10
Shares Out (MIL)
880.23
Market Cap (MIL)
6,742.56
Forward P/E
--
Dividend (Yield %)
0.59

Next Event

Q4 2020 Shandong Lukang Pharmaceutical Co Ltd Earnings Release

Latest Developments

More

Shandong Lukang Pharmaceutical to pay A shares div for FY 2017 on July 10

Shandong Lukang Pharmaceutical sees FY 2017 net profit up 292.10 pct to 309.28 pct

Shandong Lukang Pharmaceutical sets up health science and tech JV

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shandong Lukang Pharmaceutical Co., Ltd

Shandong Lukang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The Company's primary products include pharmaceutical preparation products, semi-synthetic antibiotic raw materials, veterinary antibiotics and antibiotic raw materials and others. The Company is also involved in the production and distribution of pharmaceutical intermediates. The Company distributes its products in domestic and overseas markets.

Industry

Biotechnology & Drugs

Contact Info

No. 88, Deyuan Road, High-Tech Zone

JINING, SDG

272000

China

+86.537.2983174

https://www.lkpc.com/

Executive Leadership

Xin Peng

Chairman of the Board, General Manager

Li Li

Chief Financial Officer, Finance Director

Songqiang Liu

Deputy General Manager, Director

Junting Yan

Deputy General Manager, Director

Jie Zhang

Deputy General Manager, Director

Key Stats

Price To Earnings (TTM)
26.99
Price To Sales (TTM)
1.66
Price To Book (MRQ)
2.10
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
75.48
LT Debt To Equity (MRQ)
16.88
Return on Investment (TTM)
6.35
Return on Equity (TTM)
3.66

Latest News

Latest News

BRIEF-Shandong Lukang Pharmaceutical Plans To Invest About 174.6 Mln Yuan In Production Upgrade Project

* SAYS IT PLANS TO INVEST ABOUT 174.6 MILLION YUAN ($24.69 million)IN PRODUCTION UPGRADE PROJECT Source text in Chinese: https://bit.ly/2VhAkmv Further company coverage: ($1 = 7.0728 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up